Boehringer Ingelheim Puts $80 Million into Animal Vaccine Manufacturing

Date Published12/04/2017
Author NameSara Brown
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Boehringer Ingelheim
Parent company Boehringer Ingelheim
Type of work Manufacturing
If manufacturing, is the company an OEM? Yes
Reshoring category:Foreign Direct Investment
Year reshoring announced:2017
Year reshoring implemented or to be implemented:2019
Capital investment ($):80
Country(ies) from which reshored:Germany,United States
City reshored to:St Joseph
State(s) reshored to:MO
If relevant, work nearshored to:-
Product(s) reshoredanimal vaccines
What domestic positive factors made reshoring more attractive?Eco-system synergies, Higher productivity, Impact on domestic economy
Find Reshoring Articles